VCAM1 and chronic myelogenous leukemia, BCR-ABL1 positive: The positive fraction after bead separation was analyzed with anti-human CD133 Ab and CD106 Ab (Figure 3(a)), in which 73% of the selected cells was double-positive for these two Abs when CML AP cells were injected.